Pulmonx Corporation
LUNG
$1.33
-$0.05-3.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.90% | 5.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.90% | 5.10% | |||
| Cost of Revenue | -10.18% | -7.21% | |||
| Gross Profit | -8.53% | 9.28% | |||
| SG&A Expenses | 5.42% | -10.70% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.20% | -9.46% | |||
| Operating Income | -30.83% | 31.20% | |||
| Income Before Tax | -31.90% | 25.96% | |||
| Income Tax Expenses | -19.89% | 45.31% | |||
| Earnings from Continuing Operations | -30.97% | 25.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.97% | 25.31% | |||
| EBIT | -30.83% | 31.20% | |||
| EBITDA | -34.10% | 32.81% | |||
| EPS Basic | -29.43% | 26.14% | |||
| Normalized Basic EPS | -30.34% | 26.76% | |||
| EPS Diluted | -29.43% | 26.14% | |||
| Normalized Diluted EPS | -30.34% | 26.76% | |||
| Average Basic Shares Outstanding | 1.19% | 1.14% | |||
| Average Diluted Shares Outstanding | 1.19% | 1.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||